154 related articles for article (PubMed ID: 38422655)
21. Frequent concerted genetic mechanisms disrupt multiple components of the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in thyroid cancer.
Martinez VD; Vucic EA; Pikor LA; Thu KL; Hubaux R; Lam WL
Mol Cancer; 2013 Oct; 12(1):124. PubMed ID: 24138990
[TBL] [Abstract][Full Text] [Related]
22. The role of Nrf2 signaling pathways in nerve damage repair.
Abdolmaleki A; Karimian A; Khoshnazar SM; Asadi A; Samarein ZA; Smail SW; Bhattacharya D
Toxicol Res (Camb); 2024 Jun; 13(3):tfae080. PubMed ID: 38799411
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 signaling pathway in trace metal carcinogenesis: A cross-talk between oxidative stress and angiogenesis.
Emami MH; Sereshki N; Malakoutikhah Z; Dehkordi SAE; Fahim A; Mohammadzadeh S; Maghool F
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Apr; 254():109266. PubMed ID: 35031482
[TBL] [Abstract][Full Text] [Related]
24. The dual role of Nrf2 in melanoma: a systematic review.
Malakoutikhah Z; Mohajeri Z; Dana N; Haghjooy Javanmard S
BMC Mol Cell Biol; 2023 Feb; 24(1):5. PubMed ID: 36747120
[TBL] [Abstract][Full Text] [Related]
25. The effect of Nrf
Cheraghi O; Dabirmanesh B; Ghazi F; Amanlou M; Atabakhshi-Kashi M; Fathollahi Y; Khajeh K
BMC Cancer; 2022 Sep; 22(1):979. PubMed ID: 36100939
[TBL] [Abstract][Full Text] [Related]
26. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
Li W; Huang G; Wei J; Cao H; Jiang G
Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
[TBL] [Abstract][Full Text] [Related]
27. Reactive Oxygen Species and Nuclear Factor Erythroid 2-Related Factor 2 Activation in Diabetic Nephropathy: A Hidden Target.
Abdo S; Zhang SL; Chan JS
J Diabetes Metab; 2015 May; 6(6):. PubMed ID: 26213634
[TBL] [Abstract][Full Text] [Related]
28. The Transcriptomic Response of the Murine Thyroid Gland to Iodide Overload and the Role of the Nrf2 Antioxidant System.
Chartoumpekis DV; Ziros PG; Georgakopoulos-Soares I; Smith AAT; Marques AC; Ibberson M; A Kopp P; Habeos I; Trougakos IP; Khoo NKH; Sykiotis GP
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32961913
[TBL] [Abstract][Full Text] [Related]
29. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
30. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
31. NRF2, a Superstar of Ferroptosis.
Yan R; Lin B; Jin W; Tang L; Hu S; Cai R
Antioxidants (Basel); 2023 Sep; 12(9):. PubMed ID: 37760042
[TBL] [Abstract][Full Text] [Related]
32. Activation of APE1 modulates Nrf2 protected against acute liver injury by inhibit hepatocyte ferroptosis and promote hepatocyte autophagy.
Diao J; Fan H; Zhang J; Fu X; Liao R; Zhao P; Huang W; Huang S; Liao H; Yu J; Pan D; Wang M; Xiao W; Wen X
Int Immunopharmacol; 2024 Feb; 128():111529. PubMed ID: 38244516
[TBL] [Abstract][Full Text] [Related]
33. Role of Nrf2 in chronic liver disease.
Tang W; Jiang YF; Ponnusamy M; Diallo M
World J Gastroenterol; 2014 Sep; 20(36):13079-87. PubMed ID: 25278702
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
Kose T; Sharp PA; Latunde-Dada GO
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
[TBL] [Abstract][Full Text] [Related]
35. Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin.
Wu X; Chen S; Huang K; Lin G
Mol Med Rep; 2023 Jan; 27(1):. PubMed ID: 36453238
[TBL] [Abstract][Full Text] [Related]
36. The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance.
Choi BH; Kim JM; Kwak MK
Arch Pharm Res; 2021 Mar; 44(3):263-280. PubMed ID: 33754307
[TBL] [Abstract][Full Text] [Related]
37. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.
Deshmukh P; Unni S; Krishnappa G; Padmanabhan B
Biophys Rev; 2017 Feb; 9(1):41-56. PubMed ID: 28510041
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway.
Li Y; Xu B; Ren X; Wang L; Xu Y; Zhao Y; Yang C; Yuan C; Li H; Tong X; Wang Y; Du J
Cell Mol Biol Lett; 2022 Sep; 27(1):81. PubMed ID: 36180832
[TBL] [Abstract][Full Text] [Related]
39. Ferroptosis: The functions of Nrf2 in human embryonic stem cells.
Babaei-Abraki S; Karamali F; Nasr-Esfahani MH
Cell Signal; 2023 Jun; 106():110654. PubMed ID: 36906163
[TBL] [Abstract][Full Text] [Related]
40. NRF2 addiction in cancer cells.
Kitamura H; Motohashi H
Cancer Sci; 2018 Apr; 109(4):900-911. PubMed ID: 29450944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
